Euclid Advisors’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-5,150
| Closed | -$1.25M | – | 78 |
|
|
2016
Q2 | $1.25M | Sell |
5,150
-34,763
| -87% | -$8.4M | 0.05% | 314 |
|
|
2016
Q1 | $10.4M | Sell |
39,913
-13,031
| -25% | -$3.39M | 0.39% | 81 |
|
|
2015
Q4 | $16.2M | Buy |
52,944
+20,544
| +63% | +$6.29M | 0.5% | 63 |
|
|
2015
Q3 | $9.46M | Sell |
32,400
-34,070
| -51% | -$9.94M | 0.43% | 70 |
|
|
2015
Q2 | $26.9M | Sell |
66,470
-47,780
| -42% | -$19.3M | 0.53% | 50 |
|
|
2015
Q1 | $48.2M | Buy |
114,250
+79,450
| +228% | +$33.5M | 0.89% | 19 |
|
|
2014
Q4 | $11.8M | Sell |
34,800
-122,550
| -78% | -$41.6M | 0.11% | 181 |
|
|
2014
Q3 | $52.1M | Buy |
157,350
+510
| +0.3% | +$169K | 0.37% | 59 |
|
|
2014
Q2 | $49.5M | Sell |
156,840
-13,158
| -8% | -$4.15M | 0.35% | 66 |
|
|
2014
Q1 | $52M | Buy |
169,998
+31,560
| +23% | +$9.65M | 0.39% | 52 |
|
|
2013
Q4 | $38.7M | Sell |
138,438
-11,400
| -8% | -$3.19M | 0.32% | 63 |
|
|
2013
Q3 | $36.1M | Buy |
149,838
+17,693
| +13% | +$4.26M | 0.37% | 57 |
|
|
2013
Q2 | $28.4M | Buy |
+132,145
| New | +$28.4M | 0.36% | 62 |
|